kb195

Cell therapyexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Sep 18, 2017 (NCT04603378)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03933410Phase 2Jun 30, 2019Kaleido Biosciences
NCT03797131N/AJan 6, 2019Kaleido Biosciences
NCT04603378N/ASep 18, 2017Kaleido Biosciences
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Kaleido BiosciencesFor profit3322017
1 organizations
Page 1 / 1